An Open, Randomized, Two-way Cross-over Phase I Study to Compare the Bioavailability, Safety and Tolerability of Single s.c. Doses of 300 IU XM17 With 300 IU Gonal-f in 36 Healthy, Down-regulated Young Women

Trial Profile

An Open, Randomized, Two-way Cross-over Phase I Study to Compare the Bioavailability, Safety and Tolerability of Single s.c. Doses of 300 IU XM17 With 300 IU Gonal-f in 36 Healthy, Down-regulated Young Women

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2015

At a glance

  • Drugs Follitropin alfa (Primary) ; Goserelin
  • Indications Female infertility
  • Focus Pharmacokinetics
  • Sponsors Merckle
  • Most Recent Events

    • 02 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top